NCT06782529PHASE4Recruiting

Knee Injections for Obese Patients With Knee Arthritis

Mayo Clinic

Start Date

1/24/2025

Completion Date

1/24/2027

Summary

The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.

Eligibility Criteria

Age Range: 55 years to 85 years

Inclusion Criteria: • Patients with BMI ≥30 kg/m2 and radiograph-proven knee osteoarthritis who are interested in receiving a steroid injection for knee arthritis. Exclusion Criteria: * BMI \< 30 kg/m2 * Uncontrolled diabetics with a hemoglobin A1c \> 8% * No other treatment within the time frame of the study. * Patients that are undergoing physical therapy at the time of the study.

Interventions

DRUG

Triamcinolone Acetonide Low Dose

DRUG

Triamcinolone Acetonide Standard Dose

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Osteoarthritis of Knee

Locations

Mayo Clinic in Florida

Jacksonville, Florida 32224

United States